Previous microarray analyses showed that a treatment with BA or the derivative CAI3 disrupted the regulation of genes involved in zinc homeostasis in breast cancer cells, including upregulation of metallothionein 1 (MT1), zinc transporter 1 (SLC30A1), and S100 calcium-binding protein (S100P). Here, MT1A is linked to breast cancer.